Mechanisms and biological consequences of the nuclear receptor CAR activation
Mechanisms and biological consequences of the nuclear receptor CAR activation
批准号:
10253780
负责人:
MASAHIKO NEGISHI
金额:
$259.87万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AffectAlanineAndrostanesAnimal ModelAnti-Inflammatory AgentsAntibodiesApoptosisApoptoticBindingBiologicalBrainCell Death Signaling ProcessCellsCholestasisCommunicationCytochromesDefense MechanismsDevelopmentDiabetes MellitusDiseaseDisease susceptibilityDrug InteractionsEnergy MetabolismEnvironmental ExposureEnzymesEpidermal Growth Factor ReceptorEstrogen Nuclear ReceptorEstrogen ReceptorsExcretory functionExposure toFatty AcidsGADD45A geneGenesGenetic TranscriptionGluconeogenesisGlucoseGrowthHealthHepaticHepatocyteHepatotoxicityHumanImmuneInflammationInsulin ReceptorInvestigationKnock-in MouseKupffer CellsLaboratoriesLigandsLipidsLiverLiver diseasesLiver neoplasmsMAPK3 geneMAPK8 geneMediatingMicrogliaMolecularMusMutationNeurodegenerative DisordersNuclearNuclear Hormone ReceptorsNuclear ReceptorsObesityOrganismOrphanOsteomalaciaPharmaceutical PreparationsPharmacotherapyPhenobarbitalPhosphorylationPhysiologicalPrimary carcinoma of the liver cellsProtein phosphataseProto-Oncogene Proteins c-aktReceptor ActivationRegulationRetinoidsRoleSerineSignal TransductionSystemThreonineTranscriptional ActivationTransducersVitamin D3 ReceptorWorkXenobiotic MetabolismXenobioticscell growthcell growth regulationconstitutive active receptordrug dispositiondrug metabolismenvironmental chemicalketogenesislipid biosynthesisliver metabolismmacrophagememberneutrophilnovelpregnane X receptorreceptorreceptor functionresponsesulfotransferasetranscription factortumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CAR and PXR are members of the NR1I subfamily within the nuclear receptor superfamily. My laboratory was the first to characterize CAR as a drug-activated nuclear receptor, leading world-wide investigations to characterize CAR and PXR and establish their biological roles. Both CAR and PXR regulate not only hepatic drug metabolism and disposition but also energy metabolism such as gluconeogenesis and lipogenesis and ketogenesis. In addition, they regulate cell growth and death signals as well, which includes JNK1, p38MAPK, AKT and GADD45 signals. Consequently, CAR and PXR have now been implicated in various hepatic toxicities and diseases such as liver tumors. It is now known that these receptors act as transcription factors as well as signal transducers in these regulations. However, their molecular mechanisms are not fully understood now. Our work found that CAR is phosphorylated at threonine 38 within the DBD and is inactivated. This phosphorylation is the underlying principle through which CAR functions diverge. For example, phenobarbital stimulates dephosphorization of threonine 38 by protein phosphatase 2A, by binding EGF receptor and/or insulin receptor and repressing their down-stream ERK1/2 signal for CAR activation. In PXR, phosphorylation of serine 350 within the LBD regulates its functions. These phosphorylation motifs within the DBD or LBD are conserved in the majority of nuclear receptors, suggesting that findings with CAR and PXR can be implicated in the investigations of numerous other nuclear receptors
Estrogen receptor (ER) conserves threonine 38 of CAR at serine 216 within its DBD. With a phospho-Ser216peptide antibody, it was found that ER is specifically phosphorylated at serine 216 in immune cells such as neutrophils and macrophages in mice. ER KI (Esr1S216A) mice bearing a non-phosphomimetic alanine mutation were generated to investigate the biological roles of this phosphorylation. ER KI mice are fertile but develop obesity. Analysis of brains and microglia and Kupffer cells (resident macrophages in the brain or liver) showed that this phosphorylation confers anti-inflammatory and anti-apoptotic capabilities to ER Phosphorylated ER can be a novel target to investigate various diseases such as obesity and inflammation-related neurodegenerative diseases and their mechanisms. ER KI mice can be an excellent animal model for these investigations. Retinoid related orphan receptor (ROR) conserves this phosphorylation at serine 100 within the DBD. This serine residue becomes phosphorylated in mouse livers in response to phenobarbital treatment, regulating CAR-targeted genes. These nuclear receptors appears to communicate through the conserved phosphorylation, regulating genes and disease developments in response to environmental chemicals and providing an excellent experimental system to investigate the molecular mechanism of this communication. in response to drug treatments and/or physiological/pathophysiological conditions. There are 40 nuclear receptors which conserve this motif with the DBD, enabling us to extend the same line of communication study far beyond these three nuclear receptors.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1371/journal.pone.0021229
发表时间:
2011
期刊:
PloS one
影响因子:
3.7
作者:
[Sueyoshi T, Green WD, Vinal K, Woodrum TS, Moore R, Negishi M]
通讯作者:
Negishi M
p38 MAP Kinase Links CAR Activation and Inactivation in the Nucleus via Phosphorylation at Threonine 38.
p38 MAP 激酶通过苏氨酸 38 处的磷酸化连接细胞核中的 CAR 激活和失活。
DOI:
10.1124/dmd.116.070235
发表时间:
2016
期刊:
Drug metabolism and disposition: the biological fate of chemicals
影响因子:
--
作者:
[Hori,Takeshi, Moore,Rick, Negishi,Masahiko]
通讯作者:
Negishi,Masahiko
DOI:
10.1371/journal.pone.0096092
发表时间:
2014
期刊:
PloS one
影响因子:
3.7
作者:
[Timsit YE, Negishi M]
通讯作者:
Negishi M
DOI:
10.1074/jbc.m117.806604
发表时间:
2018-01-05
期刊:
JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子:
4.8
作者:
[Shizu, Ryota, Min, Jungki, Negishi, Masahiko]
通讯作者:
Negishi, Masahiko
GR Utilizes a Co-Chaperone Cytoplasmic CAR Retention Protein to Form an N/C Interaction.
GR 利用共伴侣细胞质 CAR 保留蛋白形成 N/C 相互作用。
DOI:
10.1177/1550762918801072
发表时间:
2018
期刊:
Nuclear receptor signaling
影响因子:
--
作者:
[Ohno,Marumi, Negishi,Masahiko]
通讯作者:
Negishi,Masahiko
共 21 条
Mechanisms and biological consequences of the nuclear receptor CAR activation
-
批准号:8336594
-
项目类别:
-
资助金额:$334.72万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
Mechanisms and biological consequences of the nuclear receptor CAR activation
-
批准号:10004464
-
项目类别:
-
资助金额:$262.09万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
Mechanisms and biological consequences of the nuclear receptor CAR activation
-
批准号:9352118
-
项目类别:
-
资助金额:$235.45万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
Mechanism and biological consequences of the nuclear rec
-
批准号:7169993
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
Pharmacogenetics Of Microsomal Steroid Hydroxylases
-
批准号:6508872
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
Mechanisms and biological consequences of the nuclear receptor CAR activation
-
批准号:8929756
-
项目类别:
-
资助金额:$269.66万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
Structural Study of Sulfotransferases
-
批准号:6227948
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
Structural Biology of sulfotransferase and glycosyltrans
-
批准号:7328841
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
Structural Biology of sulfotransferase and glycosyltransferase
-
批准号:7593958
-
项目类别:
-
资助金额:$38.81万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
Mechanisms and biological consequences of the nuclear receptor CAR activation
-
批准号:8149056
-
项目类别:
-
资助金额:$384.44万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
Mechanisms and biological consequences of the nuclear receptor CAR activation
-
批准号:8734114
-
项目类别:
-
资助金额:$235.22万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
Activation Mechanism of the nuclear receptor CAR
-
批准号:7007473
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
Structural Biology of sulfotransferase and glycosyltrans
-
批准号:6838567
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
DEVELOPMENTAL PHARMACOGENETICS OF MICROSOMAL STEROID HYDROXYLASES
-
批准号:6432408
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
DEVELOPMENTAL PHARMACOGENETICS OF MICROSOMAL STEROID HYDROXYLASES
-
批准号:6290069
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
Structural Study Of Sulfotransferases
-
批准号:6508870
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
Developmental Pharmacogenetics Of Microsomal Steroid Hyd
-
批准号:6681992
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
Structural Study of Sulfotransferases
-
批准号:6432404
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
Structural Biology of sulfotransferase and glycosyltrans
-
批准号:7007467
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
Mechanism and biological consequences of the nuclear rec
-
批准号:7328859
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MASAHIKO NEGISHI
-
依托单位:
海外基金